Cargando…
Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539473/ https://www.ncbi.nlm.nih.gov/pubmed/35669992 http://dx.doi.org/10.1111/dth.15623 |
| _version_ | 1784803495852900352 |
|---|---|
| author | Pop, Samantha R. Strock, Daniel Smith, Robert J. |
| author_facet | Pop, Samantha R. Strock, Daniel Smith, Robert J. |
| author_sort | Pop, Samantha R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9539473 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95394732022-10-14 Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report Pop, Samantha R. Strock, Daniel Smith, Robert J. Dermatol Ther Letters John Wiley & Sons, Inc. 2022-06-24 2022-08 /pmc/articles/PMC9539473/ /pubmed/35669992 http://dx.doi.org/10.1111/dth.15623 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters Pop, Samantha R. Strock, Daniel Smith, Robert J. Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title | Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title_full | Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title_fullStr | Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title_full_unstemmed | Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title_short | Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report |
| title_sort | dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: a case report |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539473/ https://www.ncbi.nlm.nih.gov/pubmed/35669992 http://dx.doi.org/10.1111/dth.15623 |
| work_keys_str_mv | AT popsamanthar dupilumabforthetreatmentofpembrolizumabinducedbullouspemphigoidacasereport AT strockdaniel dupilumabforthetreatmentofpembrolizumabinducedbullouspemphigoidacasereport AT smithrobertj dupilumabforthetreatmentofpembrolizumabinducedbullouspemphigoidacasereport |